GSK Overly Squeamish About Crest Sensi-Stop Strips Claims – NAD
This article was originally published in The Rose Sheet
P&G emerges largely unscathed from a National Advertising Division dispute regarding claims for Crest Sensi-Stop Strips, which challenger GlaxoSmithKline Consumer Healthcare argued were unsupported, including the product name. NAD determined the firm’s evidence adequate to support claims of immediate relief and protection for up to one month, among other statements made in ads and on product packaging.
You may also be interested in...
NAD finds from P&G challenge that Glaxo's US consumer health business provided no evidence to support express and implied claims conveyed in two TV ads featuring animated image of a tooth surface lined with deep and narrow crevices that Sensodyne ProNamel Intensive Enamel Repair fills and heals cracked enamel.
The National Advertising Division continues work by the FTC in 2014 to crack down on inadequate disclosures, inquiring into a disclaimer used in print advertising for StriVectin Intensive Illuminating Serum. The skin-care firm will use a revised ad going forward that addresses NAD’s concerns about the disclaimer’s placement, clarity and conspicuousness.
Razor competitors Gillette and Energizer have each turned to the National Advertising Division to challenge claims made in the other's marketing, and both have been advised to modify advertising for their men's razors.